Oral Candida: clearance, colonization, or candidiasis?
Candida albicans is frequently isolated from the human mouth, yet few carriers develop clinical signs of candidiasis. Oral candidiasis presents clinically in many forms. This reflects the ability of the yeast to colonize different oral surfaces and the variety of factors which predispose the host to Candida colonization and subsequent infection. Colonization of the oral cavity appears to be facilitated by several specific adherence interactions between C. albicans and oral surfaces which enable the yeast to resist host clearance mechanisms. Thus, Candida has been shown to adhere to complement receptors, various extracellular matrix proteins, and specific sugar residues displayed on host or bacterial surfaces in the oral cavity. Oral candidiasis results from yeast overgrowth and penetration of the oral tissues when the host's physical and immunological defenses have been undermined. Tissue invasion may be assisted by secreted hydrolytic enzymes, hyphal formation, and contact sensing. While these and other phenotypic characteristics may endow certain Candida species or strains with a competitive advantage in the oral cavity, it is the host's immune competence that ultimately determines whether clearance, colonization, or candidiasis occurs.
Cannon
R D
RD
Department of Oral Biology and Oral Pathology, School of Dentistry, University of Otago, Dunedir, New Zealand.
Holmes
A R
AR
Mason
A B
AB
Monk
B C
BC
D000935:Antifungal Agents / Q000627:therapeutic use; D001422:Bacterial Adhesion / Q000502:physiology; D002176:Candida albicans / Q000201:enzymology / Q000472:pathogenicity* / Q000502:physiology; D002180:Candidiasis, Oral / Q000188:drug therapy / Q000276:immunology* / Q000382:microbiology; D004198:Disease Susceptibility; D015870:Gene Expression; D005800:Genes, Fungal; D006801:Humans; D016867:Immunocompromised Host; D009061:Mouth Mucosa / Q000382:microbiology*; D010447:Peptide Hydrolases / Q000378:metabolism; D013559:Symbiosis; D014774:Virulence / Q000235:genetics
D000935:Antifungal Agents; D010447:Peptide Hydrolases